10.1371/journal.pone.0120829.g001 Martin Rakusa Martin Rakusa Stefan J. Cano Stefan J. Cano Bernadette Porter Bernadette Porter Afsane Riazi Afsane Riazi Alan J. Thompson Alan J. Thompson Jeremy Chataway Jeremy Chataway Todd A. Hardy Todd A. Hardy Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b). Public Library of Science 2015 Individual Patients edss Corticosteroid Response corticosteroids corticosteroid treatment regression model treatment response baseline disability scores patient randomised predictive model disability status scale 6 weeks MS Relapses ObjectivesTo trial data symptom onset sclerosis impact scale 29 MSIS MS relapse variable time intervals 2015-03-18 04:31:10 Figure https://plos.figshare.com/articles/figure/_Distribution_of_baseline_EDSS_at_the_time_of_MS_relapse_a_and_improvement_in_EDSS_after_treatment_with_intravenous_methylprednisolone_b_/1341278 <p>Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b).</p>